Crinetics stock price target raised to $85 from $65 at Jones Trading

Investing.comFriday, September 26, 2025 at 11:48:57 AM
Crinetics stock price target raised to $85 from $65 at Jones Trading
Crinetics Pharmaceuticals has received a significant boost in its stock price target, now set at $85, up from $65, according to Jones Trading. This increase reflects growing confidence in the company's potential and could attract more investors, signaling a positive outlook for Crinetics in the competitive pharmaceutical market.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Crinetics stock price target raised to $77 from $65 at Morgan Stanley
PositiveFinancial Markets
Crinetics Pharmaceuticals has received a positive boost as Morgan Stanley raised its stock price target from $65 to $77. This increase reflects confidence in the company's growth potential and market performance, which is significant for investors looking for promising opportunities in the biotech sector.
Crinetics stock rating reiterated by Oppenheimer following Palsonify approval
PositiveFinancial Markets
Crinetics Pharmaceuticals has received a positive stock rating from Oppenheimer following the approval of its drug Palsonify. This endorsement is significant as it reflects confidence in the company's growth potential and the efficacy of its new treatment, which could address unmet medical needs. Investors may see this as a promising sign for future performance.
Baird raises Crinetics stock price target to $62 on Palsonify approval
PositiveFinancial Markets
Baird has raised its price target for Crinetics' stock to $62 following the approval of Palsonify, a significant development for the company. This increase reflects confidence in Crinetics' future growth and the potential impact of Palsonify in the market. Investors are likely to view this news positively, as it suggests a promising trajectory for the company's financial performance.
FDA approves Crinetics' once-daily oral acromegaly treatment
PositiveFinancial Markets
The FDA has approved Crinetics' new once-daily oral treatment for acromegaly, a condition caused by excess growth hormone. This approval is significant as it offers patients a more convenient and effective option for managing their symptoms, potentially improving their quality of life. With this advancement, Crinetics is set to make a positive impact in the healthcare landscape, providing hope for those affected by this rare disorder.
Latest from Financial Markets
Videogame Giant Electronic Arts Nears Roughly $50 Billion Deal to Go Private
PositiveFinancial Markets
Electronic Arts, a major player in the videogame industry, is reportedly close to a monumental deal that could see it go private for around $50 billion. This potential acquisition, led by investors including Silver Lake, is poised to be one of the largest leveraged buyouts in history. Such a move could reshape the future of the company and the gaming landscape, highlighting the growing interest in private investments within the tech sector.
JLR suppliers with 'days of cash' left
NegativeFinancial Markets
Concerns are rising as some businesses in the Jaguar Land Rover (JLR) supply chain reportedly have only seven to ten days of cash left, according to a Member of Parliament. This situation highlights the financial strain on suppliers, which could impact production and jobs in the automotive sector. It's a critical moment that underscores the need for support and solutions to stabilize the supply chain.
As Witkoff Pitched Mideast Peace, His Son Pitched Mideast Investors
NeutralFinancial Markets
Steve Witkoff's son is actively seeking investments from Gulf states like Qatar, which has a history of funding projects by the Witkoff family. This move comes as his father pitches for peace in the Middle East, highlighting the intersection of business and diplomacy. The involvement of Gulf investors could play a significant role in shaping future projects and relationships in the region.
Sinclair Will Bring Kimmel Back to Its ABC Affiliates
PositiveFinancial Markets
Sinclair has announced that it will resume airing 'Jimmy Kimmel Live!' on its ABC affiliates starting this Friday, ending its previous pre-emption of the popular late-night show. This decision is significant as it reflects Sinclair's commitment to providing viewers with access to popular programming, which can enhance viewer satisfaction and engagement.
Erin Burnett Net Worth 2025: CNN Salary, Career, and Family
PositiveFinancial Markets
Erin Burnett's net worth in 2025 reflects her successful career as a prominent CNN anchor and journalist. Known for her insightful reporting and engaging style, Burnett has made a significant impact in the media landscape. Her salary and financial success highlight the value of experienced journalists in today's news environment, making her a role model for aspiring reporters. This article not only sheds light on her financial achievements but also emphasizes the importance of quality journalism in informing the public.
Wolf Blitzer Net Worth 2025: CNN Salary, Career, Family and Recent News
PositiveFinancial Markets
Wolf Blitzer's net worth is projected to grow significantly by 2025, reflecting his long-standing career at CNN and his influence in the media industry. Known for his insightful reporting and engaging presence, Blitzer has become a household name, making his financial success a topic of interest. This matters because it highlights the value of experienced journalists in today's fast-paced news environment, and it showcases how media personalities can leverage their careers for financial stability.